Management of Left Atrial Myxoma
Surgical resection should be performed as soon as possible after diagnosis is established, as this is the definitive and curative treatment for left atrial myxoma. 1, 2, 3
Urgency of Surgical Intervention
The primary management principle is prompt surgical excision due to high risk of life-threatening complications, specifically:
- Systemic embolization (particularly cerebral stroke, occurring in 29% of patients) 4, 5
- Valvular obstruction causing acute heart failure or sudden cardiac death 1, 2, 3
- Complete mitral valve obstruction in large tumors 1, 4
Surgery should proceed solely on echocardiographic findings without delay for additional testing, though coronary angiography should be performed in older patients at risk for coronary artery disease 3.
Preoperative Evaluation
Transthoracic echocardiography is sufficient for diagnosis and surgical planning in most cases 3, 6. Key diagnostic features include:
- Tumor size, location, and attachment site (typically atrial septum in 90% of cases) 2
- Surface characteristics (friable/villous surfaces in 35% correlate with embolic risk) 4
- Degree of mitral valve obstruction 1, 4
Cardiac MRI provides additional anatomic detail when echocardiography is inconclusive 1.
Surgical Approach
The biatrial approach with wide excision of the tumor base and surrounding atrial septum is the gold standard technique 3. This approach:
- Allows inspection of all four cardiac chambers 3
- Minimizes tumor manipulation and fragmentation risk 3
- Facilitates complete excision with clear margins 3, 6
- Reduces recurrence rates to approximately 3% (compared to 10% with incomplete resection) 2
Right anterolateral minithoracotomy is an acceptable alternative to median sternotomy with equivalent safety, shorter ICU stay (29 vs 44 hours), shorter hospital stay (5 vs 8 days), and lower cost 7.
Perioperative Considerations
Anticoagulation is NOT routinely indicated preoperatively unless the patient has concurrent atrial fibrillation or documented thrombus 8. The embolic risk from myxoma is due to tumor fragmentation, not thrombus formation 4, 5.
For patients with concurrent atrial fibrillation requiring anticoagulation, surgery should not be delayed, as the mechanical obstruction and embolic risk from the tumor itself supersedes anticoagulation management concerns 1.
Postoperative Surveillance
Long-term echocardiographic surveillance is mandatory due to recurrence risk 2, 3, 6:
- Annual transthoracic echocardiography for at least 4-7 years, as most recurrences occur within this timeframe 4, 6
- Lifelong surveillance should be considered, particularly in younger patients and those with familial myxomas (Carney complex), where recurrence rates approach 10% 2, 6, 8
- Recurrence can occur even with pathologically confirmed clear margins 6
Prognosis
Long-term prognosis after complete surgical resection is excellent, with mortality rates of approximately 3-4% and most patients remaining asymptomatic and disease-free 3, 4. Recurrence in sporadic cases is rare (approximately 3%), but surveillance remains essential as late recurrences beyond 7 years have been documented 2, 6.